Nimbus Therapeutics Announces Clinical Progress in Oncology Therapeutic Pipeline and Provides Business Updates ...

An Austin biotech company is laying off a third of its staff following news that its primary drug candidate didn't produce ...

The global artificial intelligence in clinical trials market, valued at US$1.20 billion in 2023, is forecasted to grow at a ...

Morgan Stanley analyst Michael Ulz maintained a Hold rating on Vir Biotechnology (VIR – Research Report) today and set a price target of ...

US-based Halia Therapeutics’ new therapy will be put to a six-month-long trial that will involve 60 patients with type 2 ...

IROS and Halia Therapeutics’ clinical trial will explore a promising new therapy for obesity, specifically designed to ...

Eric Joseph, an analyst from J.P. Morgan, maintained the Hold rating on Vir Biotechnology (VIR – Research Report). The associated price target ...

Canolfan will consist of a new leisure centre, including a sports hall and fitness studios, plus a 25m swimming pool, a ...

Obudanersen sodium is under clinical development by Ionis Pharmaceuticals and currently in Phase II for Angelman Syndrome.

The "AI in Clinical Trials Market by Function, Phase, Indication, Tool, End-User & Region - Global Forecast to 2030" report ...

Dofetilide is under clinical development by Hyloris Pharmaceuticals and currently in Phase I for Atrial Flutter.

A Race Against Blindness, an Arizona-based nonprofit organization, has awarded a $1 million grant to fund research and clinical trials focused on ...